Medication info
Asmon Chewable Tablets 5 mg (Montelukast Sodium)

Asmon Chewable Tablets 5 mg (Montelukast Sodium)

Prescription medicationChewable TabletOral
Ingredient · strength
Montelukast Sodium›5.2mg / 1 tablet
Manufacturer / importer
Sinil Pharm
Appearance
Pink chewable tablets with a convex shape on both sides
Packaging
28 tablets (14 tablets/PTPX2)
Approval status
Active

MFDS item code 200906592 · Notified 2009.08.28

Summary

Main use
Prevention and long-term treatment of asthma; relief of symptoms of allergic rhinitis
Who takes it
Adults · Children
Adult dose
Take this medicine once daily. For patients with asthma, take it in the evening; for patients with allergic rhinitis, determine the time of administration according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Asthma or allergic rhinitis 5 mg chewable tablet Administer this medicine 1 hour before or 2 hours after a meal.
Child dose
Children 6~14 years: Chew 5 mg of montelukast once daily.

Ingredients

Importer
Sinil Pharm

Efficacy & effects

Prevention and long-term treatment of asthma; relief of symptoms of allergic rhinitis

  • Asthma
  • allergic rhinitis
View approved original text

This medicine is used for the prevention and long-term treatment of asthma. It also helps relieve symptoms such as nasal congestion and sneezing due to seasonal and perennial allergic rhinitis. It assists patients in maintaining respiratory health and effectively managing symptoms.

How to take

Adult dose

Take this medicine once daily. For patients with asthma, take it in the evening; for patients with allergic rhinitis, determine the time of administration according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Asthma or allergic rhinitis 5 mg chewable tablet Administer this medicine 1 hour before or 2 hours after a meal.

Child dose

Children 6~14 years: Chew 5 mg of montelukast once daily.

Precautions

This medication contains the artificial sweetener aspartame and should not be used by patients with phenylketonuria, a genetic disorder. The intake of aspartame should be regulated within the recommended limits by WHO, ensuring that adults do not exceed 2.4 grams per day. Additionally, due to the presence of lactose in this medication, patients with galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medicine. During the use of this medication, adverse reactions such as fatigue, fever, abdominal pain, indigestion, headache, nasal congestion, cough, and rash may occur, so if symptoms persist or worsen, consultation with a physician is necessary. Particularly in patients with asthma or allergic rhinitis, various adverse reactions have been reported, so caution is needed. This medication is not intended for use during acute asthma attacks; appropriate emergency medication should be used when symptoms are acute. Inhaled corticosteroid preparations should not be abruptly discontinued or replaced with this medication; they should be adjusted gradually under the guidance of a physician. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should not take these medications concurrently with this medicine. While taking this medication, symptoms related to eosinophilia or vasculitis may occur, thus the physician should closely monitor the patient's condition. Women who are pregnant or breastfeeding should only take this medication if necessary and should be cautious, as this medication may be secreted in breast milk. It can also be used in children and the elderly, but proper dosage and administration methods should be followed considering safety and efficacy based on age. In case of overdose, since there is no specific antidote, general symptomatic treatment and clinical monitoring are required. This medication is light sensitive, so it should be opened just before use and taken immediately after preparation. It must be kept out of reach of children. If any neurological or psychiatric symptoms occur while taking this medication, notify the physician immediately and do not arbitrarily discontinue or reduce the dosage of other asthma treatments.

Side effects

  • Weakness
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • indigestion
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 78 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otitis media
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • ear pain
  • enteritis
  • eczema
  • hives
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory tract infection
  • wheezing
  • otitis
  • tonsillitis
  • drowsiness
  • aggressive behavior
  • restlessness
  • anxiety
  • depression
  • disorientation
  • attention deficit
  • sleep disorders
  • hallucinations
  • insomnia
  • memory impairment
  • psychomotor hyperactivity
  • sleepwalking
  • suicidal ideation
  • behavioral disorders
  • tics
  • perceptual disturbances
  • decreased perception
  • convulsive seizures
  • palpitations
  • nosebleeds
  • pulmonary eosinophilia
  • diarrhea
  • vomiting
  • cholestatic hepatitis
  • hepatocellular liver damage
  • mixed-type liver damage
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • hives
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • nocturnal enuresis
  • edema
  • systemic eosinophilia
  • vasculitis
  • thrombocytopenia
  • increased bleeding frequency

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to moisture and light, so it should be stored at room temperature between 1 to 30 degrees Celsius. It is also important to keep the medication in a tightly sealed container to prevent contact with air.

Appearance and packaging

Appearance

Pink chewable tablets with a convex shape on both sides

Package unit

28 tablets (14 tablets/PTPX2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.